Back to News
Market Impact: 0.15
Legend Biotech Announces 7 Presentations at the 68th American Society of Hematology Annual Meeting
Source: Nasdaq
Healthcare & BiotechProduct Launches
Legend Biotech said it will present information on CARVYKTI at the 68th ASH Annual Meeting in New Orleans, December 12–15, 2026. The article text is truncated after stating the presentations will highlight new clinical and real-world information, so it provides no further data or results to assess.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
LEGN0.35
More News
- SpaceX signs deal with Qualcomm to provide network technology for U.S. mobile service
- How Abdul El-Sayed would build Medicare for All, from a wealth tax to a Fed-style governing board
- BillionToOne SVP John ten Bosch sells $320,723 in stock
- CVS Plans to Break Up $117 Billion Healthcare Conglomerate
- Sight Sciences earnings missed by $0.48, revenue topped estimates
- Novo raises full-year outlook as Wegovy sales impress